WOODFIELD MEDICAL — All Prescriptions & Medications — Page 13
Practice Code: B81031 | GRIMSBY, DN34 4GB
Showing results 601-650 of 721
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| 18 | 560 | £3.6K | +122.6% ▲ | |
| Naloxegol | 17 | 570 | £997 | +23.3% ▲ |
| Budesonide | 17 | 17 | £165 | +9.3% ▲ |
| 17 | 350 | £1.5K | -61.3% ▼ | |
| 17 | 3,030 | £2.1K | +52.9% ▲ | |
| Zinc oxide | 16 | 461 | £55 | -22.7% ▼ |
| Methylphenidate hydrochloride | 16 | 448 | £572 | -93.8% ▼ |
| Levodopa/carbidopa/entacapone | 16 | 2,160 | £1.4K | -42.8% ▼ |
| Erythromycin ethylsuccinate | 16 | 1,388 | £141 | -31.5% ▼ |
| Oestrogens conjugated | 16 | 1,848 | £709 | -21.6% ▼ |
| Hepatitis B | 16 | 16 | £512 | +51.2% ▲ |
| 16 | 684 | £3.4K | +153.5% ▲ | |
| 16 | 80 | £243 | +94.9% ▲ | |
| 16 | 2,220 | £5.6K | +8.1% ▲ | |
| 16 | 810 | £3.3K | -38.1% ▼ | |
| 16 | 930 | £2.3K | +5.0% ▲ | |
| Mizolastine | 15 | 420 | £94 | +301.8% ▲ |
| Hyoscine | 15 | 180 | £1.2K | +116.1% ▲ |
| Rifaximin | 15 | 840 | £3.9K | -44.1% ▼ |
| Magnesium aspartate | 15 | 420 | £379 | -0.9% vs avg |
| Tube feed 1.5 kcal/ml peptide based (0914041) | 15 | 411.0K | £13.4K | +40.9% ▲ |
| Clindamycin/tretinoin | 15 | 690 | £261 | +27.8% ▲ |
| Clindamycin phosphate | 15 | 720 | £139 | -8.8% ▼ |
| Imiquimod | 15 | 224 | £849 | +111.1% ▲ |
| 15 | 946 | £4.3K | -17.7% ▼ | |
| 15 | 150 | £490 | -51.2% ▼ | |
| 15 | 84 | £192 | -9.1% ▼ | |
| 15 | 179 | £211 | +10.4% ▲ | |
| 15 | 820 | £2.9K | -60.1% ▼ | |
| 15 | 450 | £949 | +6.0% ▲ | |
| Telmisartan | 14 | 784 | £271 | -75.9% ▼ |
| Indacaterol/glycopyrronium | 14 | 420 | £432 | -69.0% ▼ |
| Tapentadol | 14 | 784 | £523 | -66.0% ▼ |
| Testosterone enantate | 14 | 14 | £456 | +96.0% ▲ |
| Potassium chloride | 14 | 1,340 | £112 | -25.1% ▼ |
| Ascorbic acid | 14 | 504 | £763 | -31.8% ▼ |
| Dexamethasone sodium metasulphobenzoate | 14 | 112 | £100 | +88.4% ▲ |
| Aciclovir | 14 | 108 | £101 | +13.6% ▲ |
| 14 | 400 | £4.3K | +33.9% ▲ | |
| 14 | 363 | £190 | +41.2% ▲ | |
| 14 | 2,800 | £74 | +8.5% ▲ | |
| 14 | 40 | £1.3K | +53.7% ▲ | |
| 14 | 420 | £781 | +9.4% ▲ | |
| 14 | 840 | £464 | +35.6% ▲ | |
| 14 | 1,440 | £4.0K | +22.2% ▲ | |
| 14 | 420 | £1.9K | +19.2% ▲ | |
| Zolpidem tartrate | 13 | 364 | £16 | -85.6% ▼ |
| Trifluoperazine | 13 | 364 | £184 | -13.8% ▼ |
| Glucagon | 13 | 21 | £304 | -14.5% ▼ |
| Betamethasone sodium phosphate | 13 | 916 | £120 | +5.7% ▲ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.